Zhejiang Jiuzhou Pharmaceutical Co Ltd banner
Z

Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456

Watchlist Manager
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Watchlist
Price: 13.96 CNY -1.34% Market Closed
Market Cap: ¥12.4B

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Cash Equivalents
¥2.7B
CAGR 3-Years
N/A
CAGR 5-Years
29%
CAGR 10-Years
33%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhejiang Nhu Co Ltd
SZSE:002001
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash Equivalents
¥2.2m
CAGR 3-Years
N/A
CAGR 5-Years
-45%
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Glance View

Market Cap
12.4B CNY
Industry
Pharmaceuticals

Founded in 1973, Zhejiang Jiuzhou Pharmaceutical Co. Ltd. has steadily navigated the evolving tides of the global pharmaceutical industry with a compelling blend of innovation and traditional business acumen. Rooted in China's dynamic Zhejiang province, the company initially focused on manufacturing basic pharmaceutical intermediates. Over the years, it strategically expanded its operations, becoming a key player in both the Active Pharmaceutical Ingredients (APIs) and Contract Development and Manufacturing Organization (CDMO) sectors. This dual focus has allowed Jiuzhou Pharmaceutical to innovate and offer comprehensive services, ranging from drug development to commercial manufacturing, effectively appealing to a broad range of customers including some of the world's leading pharmaceutical companies. At the heart of Jiuzhou Pharmaceutical's success lies its commitment to research and development, a cornerstone that supports its diversification strategy. The company leverages its extensive expertise and cutting-edge technology to improve existing drugs while also participating in the development of new, patented pharmaceuticals. By fostering strong partnerships with global pharmaceutical giants, Jiuzhou effectively integrates itself into the larger pharmaceutical ecosystem, providing customized solutions that resonate with market demand. This business model not only reinforces its financial growth but also establishes Zhejiang Jiuzhou as an indispensable contributor to advancements in medicine, continually enhancing its reputation on the international stage.

Intrinsic Value
20.47 CNY
Undervaluation 32%
Intrinsic Value
Price ¥13.96
Z

See Also

What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Cash Equivalents?
Cash Equivalents
2.7B CNY

Based on the financial report for Mar 31, 2026, Zhejiang Jiuzhou Pharmaceutical Co Ltd's Cash Equivalents amounts to 2.7B CNY.

What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
33%

Over the last year, the Cash Equivalents growth was -2%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett